1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. CXO Perspective
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. CHINA DRUG DELIVERY MARKET, BY TYPE
5.1. Introduction
5.2. Inhalation Drug Delivery
5.2.1. Market Opportunities and Trends
5.2.2. Growth Prospects
5.2.3. Geographic Lucrativeness
5.3. Injectable Drug Delivery
5.3.1. Market Opportunities and Trends
5.3.2. Growth Prospects
5.3.3. Geographic Lucrativeness
5.4. Nasal Drug Delivery
5.4.1. Market Opportunities and Trends
5.4.2. Growth Prospects
5.4.3. Geographic Lucrativeness
5.5. Oral Drug Delivery
5.5.1. Market Opportunities and Trends
5.5.2. Growth Prospects
5.5.3. Geographic Lucrativeness
5.6. Transdermal Drug Delivery
5.6.1. Market Opportunities and Trends
5.6.2. Growth Prospects
5.6.3. Geographic Lucrativeness
6. CHINA DRUG DELIVERY MARKET, BY APPLICATION
6.1. Introduction
6.2. Disease Treatment
6.2.1. Market Opportunities and Trends
6.2.2. Growth Prospects
6.2.3. Geographic Lucrativeness
6.3. Research/academic purpose
6.3.1. Market Opportunities and Trends
6.3.2. Growth Prospects
6.3.3. Geographic Lucrativeness
7. CHINA DRUG DELIVERY MARKET, BY GEOGRAPHY
7.1. Introduction
7.2. Market Opportunities and Trends
7.3. Growth Prospects
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. COMPANY PROFILES
9.1. Gerresheimer AG
9.2. Pfizer Inc.
9.3. Shanghai Fosun Pharmaceutical
9.4. Hutchison China MediTech Limited
9.5. GL Montrose
9.6. Becton, Dickinson and company